Association of single-pool Kt/V with sarcopenia in patients receiving maintenance hemodialysis

Background: Sarcopenia is common among patients receiving maintenance hemodialysis, but the relationship between dialysis adequacy and sarcopenia remains uncertain. Because single-pool Kt/V (spKt/V) is influenced by both delivered dialysis dose and body size, its association with muscle loss may be complex. Methods We conducted a single-center retrospective cross-sectional study of 436 adults receiving maintenance hemodialysis. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. spKt/V was analyzed continuously and according to clinically relevant categories (≥1.4, 1.2–1.4, and < 1.2). Multivariable logistic regression was used to evaluate the association between spKt/V and sarcopenia. Restricted cubic splines were used to assess nonlinearity, and prespecified subgroup analyses evaluated potential effect modification. Results Among 436 patients, 141 (32.3%) had sarcopenia. Median spKt/V was lower in patients with sarcopenia than in those without sarcopenia (1.06 [0.87–1.26] vs. 1.41 [1.26–1.51]; P < 0.001). After adjustment for age, sex, hypertension, diabetes, and dialysis vintage, each 0.1-unit lower spKt/V was associated with higher odds of sarcopenia (OR, 2.25; 95% CI, 1.87–2.71). Compared with patients with spKt/V ≥1.2, those with spKt/V < 1.2 had substantially higher odds of sarcopenia (OR, 18.42; 95% CI, 9.31–36.46). Sarcopenia prevalence increased across descending spKt/V categories (9.6% for ≥1.4, 21.7% for 1.2– < 1.4, and 64.9% for < 1.2; adjusted P for trend < 0.001 from an ordinal-category model). Restricted cubic spline analysis showed a nonlinear association ( P = 0.002), with a steeper increase in the odds of sarcopenia at spKt/V values below approximately 1.2. Conclusions Lower spKt/V was associated with prevalent sarcopenia, with a nonlinear pattern that was more marked at lower values. The apparent threshold near 1.2 is exploratory and should not be interpreted as a causal treatment target. Residual kidney function was not available, substantially limiting assessment of total kidney-plus-dialysis clearance and leaving potential residual confounding. Prospective multicenter studies are needed to clarify the temporal relationship and evaluate spKt/V alongside other measures of muscle health.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-11-16
DOI
https://doi.org/10.3389/fnut.2026.1990247
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of single-pool Kt/V with sarcopenia in patients receiving maintenance hemodialysis

Xueyan Yang, Yan Du, Hao Wu
1 links
Frontiers in Nutrition
Dialysis and Renal Disease Management
article

Association of single-pool Kt/V with sarcopenia in patients receiving maintenance hemodialysis

Xueyan Yang, Yan Du, Hao Wu
article en

Abstract

Background: Sarcopenia is common among patients receiving maintenance hemodialysis, but the relationship between dialysis adequacy and sarcopenia remains uncertain. Because single-pool Kt/V (spKt/V) is influenced by both delivered dialysis dose and body size, its association with muscle loss may be complex. Methods We conducted a single-center retrospective cross-sectional study of 436 adults receiving maintenance hemodialysis. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. spKt/V was analyzed continuously and according to clinically relevant categories (≥1.4, 1.2–1.4, and < 1.2). Multivariable logistic regression was used to evaluate the association between spKt/V and sarcopenia. Restricted cubic splines were used to assess nonlinearity, and prespecified subgroup analyses evaluated potential effect modification. Results Among 436 patients, 141 (32.3%) had sarcopenia. Median spKt/V was lower in patients with sarcopenia than in those without sarcopenia (1.06 [0.87–1.26] vs. 1.41 [1.26–1.51]; P < 0.001). After adjustment for age, sex, hypertension, diabetes, and dialysis vintage, each 0.1-unit lower spKt/V was associated with higher odds of sarcopenia (OR, 2.25; 95% CI, 1.87–2.71). Compared with patients with spKt/V ≥1.2, those with spKt/V < 1.2 had substantially higher odds of sarcopenia (OR, 18.42; 95% CI, 9.31–36.46). Sarcopenia prevalence increased across descending spKt/V categories (9.6% for ≥1.4, 21.7% for 1.2– < 1.4, and 64.9% for < 1.2; adjusted P for trend < 0.001 from an ordinal-category model). Restricted cubic spline analysis showed a nonlinear association ( P = 0.002), with a steeper increase in the odds of sarcopenia at spKt/V values below approximately 1.2. Conclusions Lower spKt/V was associated with prevalent sarcopenia, with a nonlinear pattern that was more marked at lower values. The apparent threshold near 1.2 is exploratory and should not be interpreted as a causal treatment target. Residual kidney function was not available, substantially limiting assessment of total kidney-plus-dialysis clearance and leaving potential residual confounding. Prospective multicenter studies are needed to clarify the temporal relationship and evaluate spKt/V alongside other measures of muscle health.

Frontiers in NutritionVol. 13
Xi'an Medical University (CN), Lanzhou University Second Hospital (CN), Lanzhou University (CN)
Good health and well-being
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon